InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,591.32
(
-0.76%
)
US TECH 100
19,789.20
(
-1.64%
)
Dow Jones
39,823.40
(
0.26%
)
Brent Oil
85.08
(
0.04%
)
Bitcoin
57,395.66
(
-0.63%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

LasNubes

Send PM Follow Ignore
Followers 40
Posts 2492
Boards Moderated 0
Alias Born 04/07/2012

LasNubes

Re: kei post# 3641

Friday, 12/05/2014 8:11:30 AM

Friday, December 05, 2014 8:11:30 AM

Post# of 23979
OREX.
They have 800 Takeda drug reps in the field pushing Contrave in the U.S. with sales numbers to be reported in Q1.
The U.S. market alone should justify the price target. EU approval would be gravy.
JMHO

good luck!

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up